Understanding how HSP70 helps cells cope with heat stress
Regulation of HSP70 function during heat stress tolerance
This study is looking at how a special protein called HSP70 helps our cells handle stress, especially when it gets too hot, and it could lead to new treatments for diseases like cancer and heart problems.
Quick facts
| Grant type | R15 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Mississippi NIH-funded |
| Lab location | 1 site (University, United States) |
| Project ID | NIH-11043641 on NIH RePORTER |
What this research studies
This research investigates the role of the 70-kilodalton heat shock protein (HSP70) in helping cells manage stress, particularly during heat exposure. By studying how HSP70 functions at a molecular level, the research aims to uncover its importance in various diseases, including cancer and cardiovascular disorders. The approach involves examining the structure and function of HSP70 to identify how it maintains cellular health and responds to stress. This knowledge could lead to new therapeutic strategies for diseases linked to HSP70 dysfunction.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals affected by diseases associated with HSP70 dysfunction, such as cancer or cardiovascular diseases.
Not a fit: Patients with conditions unrelated to HSP70 or those not experiencing heat stress-related issues may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to innovative treatments for diseases like cancer and cardiovascular disorders by targeting HSP70 pathways.
How similar studies have performed: Previous research has shown promising results in targeting heat shock proteins for therapeutic purposes, indicating potential success for this approach.
Where this research is happening
University, United States
- University of Mississippi — University, United States (Active)
Researchers
- Principal investigator: Qiu, Yongjian — University of Mississippi
- Study coordinator: Qiu, Yongjian
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.